Multimodal Endoscopic Diagnostics of Gastric Type I Neuroendocrine Tumors Abstract #1513

Introduction: From 1998 till 2014 in our institution we have diagnosed 72 type I gastric neuroendocrine tumors (NET) with upper gastrointestinal endoscopy.
Aim(s): At early stage (up to 2006) only white-light endoscopy was used for gastric NET diagnostics and all of them appeared as flat or polypoid reddish lesions in proximal stomach or gastric corpus. Since 2007 we started use narrow-band imaging (NBI) endoscopy and it allowed more accurate gastric NET diagnostics.
Materials and methods: All lesions with NBI examination had altered mucosal pit pattern: tortuous or dot-type. Moreover, with NBI it is possible to review not only pit pattern, but microvessel pattern also, and in all type I gastric NET we observed pathologic arborescent dilated microvessels. Use of NBI endoscopy with x150 magnification allowed comprehensive diagnostics of very small (less than 0,1 cm) lesions, and additional 43,2% gastric type I NETs were found only with such diagnostic approach.
Conference: 13th Annual ENETS conference (2016)
Category: Imaging (radiology, nuclear medicine, endoscopy)
Presenting Author: Dr. Sergey Pirogov

To read results and conclusion, please login ...

Further abstracts you may be interested in

#407 Co-existing Type-1 Gastric Neuroendocrine Tumors (NETs) and Adenocarcinoma in Autoimmune Associated Atrophic Gastritis
Introduction: Autoimmune gastritis (AIG) causes oxyntic gland atrophy. This condition is often associated with Type-1 gastric NET secondary to achlorhydria and hypergastrinemia. Similar to atrophic gastritis in non-autoimmune conditions, AIG is associated with intestinal metaplasia that could progress to glandular dysplasia.
Conference: 9th Annual ENETS Conference (2012)
Category: Clinical
Presenting Author: Laura Tang
Authors: Tang L
#1512 Type I Gastric Neuroendocrine Tumors Diagnostics: 16 Years of Experience
Introduction: In our institution from 1998 to 2014 we have identified 72 patients with type I gastric neuroendocrine tumors (NET).
Conference: 13th Annual ENETS conference (2016)
Category: Imaging (radiology, nuclear medicine, endoscopy)
Presenting Author: Dr. Sergey Pirogov
#1516 Multimodal Endoscopic Diagnostics of Gastric Neuroendocrine Tumors
Introduction: From 1998 till 2014 in our institution we have diagnosed 72 type I gastric neuroendocrine tumors (NET) with upper gastrointestinal endoscopy.
Conference: 13th Annual ENETS conference (2016)
Category: Imaging (radiology, nuclear medicine, endoscopy)
Presenting Author: Dr. Sergey Pirogov
#1519 Gastric Type I Neuroendocrine Tumors Endoscopic Treatment Options
Introduction: From 1998 till 2014 in our institution we have identified 72 patients with type I gastric neuroendocrine tumors (NET), 42 of them, without regional or distant metastases, undergone different types of endoscopic treatment.
Conference: 13th Annual ENETS conference (2016)
Category: PRRT-Ablative therapies-Endoscopic treatment
Presenting Author: Dr. Sergey Pirogov
Keywords: gastric, NET, endoscopic, EMR, ESD, APC
#622 Evaluation of Mucin and Neuroendocrine Expression in Diffuse Gastric Cancer with Signet Ring Cell Morphology
Introduction: A proportion of diffuse gastric carcinoma, according to the Lauren classification system, has signet ring cell morphology. Signet ring cells are characterized by a peripherally placed nucleus and a central amorphous substance, which is reported to be mucin based on Periodic Acid Schiff positivity (PAS). PAS is not a specific staining method for mucin. Neuroendocrine expression has previously been reported in tumor cells in diffuse type gastric cancer.
Conference: 10th Annual ENETS Conference (2013)
Category: Basic Science - mTOR and other pathways, signalling, receptors
Presenting Author: MD, PhD Øystein Sørdal